Meng Hui Lin
Director/Board Member at PACGEN LIFE SCIENCE CORPORATION
Network origin in Meng Hui Lin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical Specialties | 12 | |
| Subsidiary | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Meng Hui Lin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Chung Yuan Christian University | College/University | Undergraduate Degree Masters Business Admin | |
| Santa Clara University | College/University | Masters Business Admin Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
UMC Japan
 UMC Japan SemiconductorsElectronic Technology UMC Japan engages in the manufacture and sale of semiconductor memory chips, logical integrated circuits and other original equipment such as LCD drivers, controllers, memories for mobile telephones, optical disc drivers for DVD players. It is also involved in providing technical support service. Its operations are carried out through the following divisions: Logic products; Memory products (semiconductor memory chips), Purchased products and Other. It is a subsidiary of Taiwan-based United Microelectronics Corp. The company was founded in May 1984 and is headquartered in Tateyama, Japan. | Semiconductors | Chairman | |
Eluminex Biosciences (Suzhou) Ltd.
 Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Biotechnology | Director/Board Member | |
| Hong Kong Chlitina International Ltd. | Director/Board Member | ||
| Chlitina Intelligence Ltd. | Director/Board Member | ||
| Chlitina International Ltd. | Director/Board Member | ||
| Chlitina Group Ltd. | Director/Board Member | ||
| Tongji University | College/University | Graduate Degree | |
| CHLITINA HOLDING LIMITED | Household/Personal Care | Chief Executive Officer | |
| National Taipei University of Technology | College/University | Undergraduate Degree | |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Pharmaceuticals: Major | Director/Board Member | |
| Wealthy Garden Investment Ltd. | Director/Board Member | ||
Innoforce Pharmaceuticals Co. Ltd.
 Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member | |
Kira Pharmaceuticals (Hong Kong) Ltd.
 Kira Pharmaceuticals (Hong Kong) Ltd. Pharmaceuticals: MajorHealth Technology Kira Pharmaceuticals (Hong Kong) Ltd. manufactures pharmaceuticals. The private company is based in Hong Kong, Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Medical Distributors | Director/Board Member | |
Jing Medicine Technology Shanghai Ltd.
 Jing Medicine Technology Shanghai Ltd. BiotechnologyHealth Technology Jing Medicine Technology Shanghai Ltd. develops therapeutic monoclonal antibody and small molecule drugs. The private company is based in Shanghai, China. | Biotechnology | Director/Board Member | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
| ZAI LAB LIMITED | Biotechnology | Founder | |
| The BayHelix Group | Corporate Secretary | ||
| China Healthcare Consortium Ltd. | Director/Board Member | ||
| Burrill & Co. Venture Capital | Chief Executive Officer | ||
| TAIWAN LIPOSOME COMPANY, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Chlitina Marketing Ltd. | Director/Board Member | ||
| J&R International Holding Ltd. | Director/Board Member | ||
| University of Michigan | College/University | Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| National Taiwan University | College/University | Graduate Degree | |
| ALBATRON TECHNOLOGY CO., LTD | Electronic Production Equipment | Director/Board Member | |
| Everich Consulting, Inc. | Director/Board Member | ||
| Der Kang Biology Technology Co., Ltd. | Corporate Secretary | ||
| Vanung University | College/University | Undergraduate Degree | |
| Soochow University /Taiwan/ | College/University | Graduate Degree | |
| National Yang Ming University | College/University | Graduate Degree | |
| INTECH BIOPHARM CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
| Sch Electronic Co., Ltd. | Chief Tech/Sci/R&D Officer | ||
| MICROBASE TECHNOLOGY CORP. | Medical Specialties | Director/Board Member | |
| FORMOSA LABORATORIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| Hong Kong Crystal Asia International Ltd. | Director/Board Member | ||
| U-NEURON BIOMEDICAL INC | Miscellaneous Commercial Services | Director/Board Member | |
| Charming Biotech Corp. | Director/Board Member | ||
| Zhaocang (Shanghai) Trading Co. Ltd. | Director/Board Member | ||
| Jin Yen (Shanghai) Biotech Co. Ltd. | Director/Board Member | ||
| Keuka College | College/University | Doctorate Degree | |
| Wuguan (Shanghai) Trade Ltd. | Director/Board Member | ||
| Weihu (Shanghai) Trade Ltd. | Director/Board Member | ||
| Weishuo (Shanghai) Daily Product Ltd. | Director/Board Member |
Statistics
International
| Taiwan | 19 |
| China | 13 |
| United States | 8 |
| Hong Kong | 5 |
| Cayman Islands | 3 |
Sectoral
| Consumer Services | 13 |
| Health Technology | 12 |
| Electronic Technology | 3 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 74 |
| Chairman | 22 |
| Independent Dir/Board Member | 20 |
| Chief Executive Officer | 8 |
| Undergraduate Degree | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Ming-Chih Hsuan | 28 |
| Chung Yue Wang | 23 |
| Pi Hua Chen | 22 |
| Marietta Wu | 19 |
| Christina Yip | 6 |
| Che Jen Chuang | 6 |
| Chia Shang Chen | 5 |
| Chien Ju Lin | 4 |
| Tsung Ching Lin | 3 |
| Frank Lin | 3 |
| Meng Te Lin | 3 |
| Hsiang Hui Kung | 3 |
| Chin Lieh Wu | 2 |
| Vincent Chen | 1 |
| En Jung Tsao | 1 |
- Stock Market
- Insiders
- Meng Hui Lin
- Company connections
